Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
Martin SjostromLinda HartmanGabriella HonethDorthe GrabauPer MalmströmCecilia HegardtMårten FernöEmma NiméusPublished in: Journal of clinical pathology (2015)
ALDH1A1 is associated with DDFS and clinicopathological variables, both in cancer cells and stroma, but is highly cut-off dependent. Only the strongly ALDH1A1-stained cells show a more aggressive phenotype typical for CSCs.